Levothyroxine Sodium Tablet
Product Images NDC 59651-556

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 59651-556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (137 mcg (90 Tablets Bottle))

Package Label-principal Display Panel (137 mcg (90 Tablets Bottle))
Label for Levothyroxine Sodium Tablets USP, 137 mcg (0.137 mg) oral tablets by Aurobindo Pharma Limited. The label indicates 90 tablets per bottle, distributed by Aurobindo Pharma USA, Inc., with storage instructions and warnings to protect from light and moisture. It also shows the NDC number 59651-554-90 and includes a small image of a round blue tablet imprinted with '137'.*
FDA Label Image

Package Label-principal Display Panel (150 mcg (90 Tablets Bottle))

Package Label-principal Display Panel (150 mcg (90 Tablets Bottle))
Label for Levothyroxine Sodium Tablets, USP 150 mcg (0.15 mg) oral tablets by Aurobindo Pharma Limited. The label includes NDC 59651-555-90 and indicates a bottle containing 90 tablets. Storage instructions specify controlled room temperature, protection from light and moisture, and dispensing in a tight, light-resistant container. Distributed by Aurobindo Pharma USA, Inc., made in India.*
FDA Label Image

Package Label-principal Display Panel (175 mcg (90 Tablets Bottle))

Package Label-principal Display Panel (175 mcg (90 Tablets Bottle))
Label for Levothyroxine Sodium Tablets, USP 175 mcg (0.175 mg), oral tablets. The label indicates a package of 90 tablets distributed by Aurobindo Pharma USA, Inc., made in India. It includes storage instructions, dosage reference to package insert, and container handling precautions, along with a barcode and NDC number 59651-556-90.*
FDA Label Image

Package Label-principal Display Panel (200 mcg (90 Tablets Bottle))

Package Label-principal Display Panel (200 mcg (90 Tablets Bottle))
Label for Levothyroxine Sodium Tablets, USP 200 mcg (0.2 mg) oral tablets by Aurobindo Pharma Limited. The bottle contains 90 tablets. The label includes storage instructions, dosage advisory, distributor information (Aurobindo Pharma USA, Inc., East Windsor, NJ), and a barcode.*
FDA Label Image

Package Label-principal Display Panel (300 mcg (90 Tablets Bottle))

Package Label-principal Display Panel (300 mcg (90 Tablets Bottle))
Label for Levothyroxine Sodium Tablets, USP 300 mcg (0.3 mg) by Aurobindo Pharma Limited. It shows a round green tablet and states the package contains 90 tablets. Storage instructions and distributor information for Aurobindo Pharma USA, Inc. in East Windsor, NJ, are included along with NDC 59651-558-90.*
FDA Label Image

Str (Levothyroxine Str)

Str (Levothyroxine Str)
Chemical structure of Levothyroxine Sodium showing iodine-substituted phenyl rings connected through an ether linkage, with an amino acid side chain and sodium carboxylate group, indicating its molecular composition including water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.